413 related articles for article (PubMed ID: 34050913)
81. Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study.
Triggianese P; Guarino MD; Pellicano C; Borzi M; Greco E; Modica S; De Carolis C; Perricone R
Int Arch Allergy Immunol; 2017; 172(1):55-63. PubMed ID: 28222436
[TBL] [Abstract][Full Text] [Related]
82. Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema.
Piras V; Alves F; Gonçalo M
Dermatol Ther; 2019 Nov; 32(6):e13098. PubMed ID: 31579975
[TBL] [Abstract][Full Text] [Related]
83. A Nationwide Study of Norwegian Patients with Hereditary Angioedema with C1 Inhibitor Deficiency Identified Six Novel Mutations in SERPING1.
Johnsrud I; Kulseth MA; Rødningen OK; Landrø L; Helsing P; Waage Nielsen E; Heimdal K
PLoS One; 2015; 10(7):e0131637. PubMed ID: 26154504
[TBL] [Abstract][Full Text] [Related]
84. Endothelial cell activation during edematous attacks of hereditary angioedema types I and II.
Kajdácsi E; Jani PK; Csuka D; Varga LÁ; Prohászka Z; Farkas H; Cervenak L
J Allergy Clin Immunol; 2014 Jun; 133(6):1686-91. PubMed ID: 24522092
[TBL] [Abstract][Full Text] [Related]
85. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
[TBL] [Abstract][Full Text] [Related]
86. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
Bork K
Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
[TBL] [Abstract][Full Text] [Related]
87. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
Riedl M
Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
[TBL] [Abstract][Full Text] [Related]
88. Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor.
Moreno AS; Valle SO; Levy S; França AT; Serpa FS; Arcuri HA; Palma MS; Campos WN; Dias MM; Ponard D; Monnier N; Lunardi J; Bork K; Silva WA; Arruda LK
Int Arch Allergy Immunol; 2015; 166(2):114-20. PubMed ID: 25790805
[TBL] [Abstract][Full Text] [Related]
89. Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey.
Farkas H; Kőhalmi KV; Visy B; Veszeli N; Varga L
J Allergy Clin Immunol Pract; 2020; 8(7):2379-2383. PubMed ID: 32198128
[TBL] [Abstract][Full Text] [Related]
90. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):492-8. PubMed ID: 25872948
[TBL] [Abstract][Full Text] [Related]
91. Hereditary angioedema in a single family with specific mutations in both plasminogen and SERPING1 genes.
Bork K; Zibat A; Ferrari DM; Wollnik B; Schön MP; Wulff K; Lippert U
J Dtsch Dermatol Ges; 2020 Mar; 18(3):215-223. PubMed ID: 32065705
[TBL] [Abstract][Full Text] [Related]
92. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
[TBL] [Abstract][Full Text] [Related]
93. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].
Jacquin-Porretaz C; Castelain F; Daguindau E; Seilles E; Nardin C; Aubin F; Pelletier F
Ann Dermatol Venereol; 2018 Oct; 145(10):598-602. PubMed ID: 29673745
[TBL] [Abstract][Full Text] [Related]
94. [Hereditary angioedema: new mechanisms and therapeutic options].
Reshef A; Leibovich I; Goren A; Kidon M
Harefuah; 2009 Aug; 148(8):529-34, 571. PubMed ID: 19899257
[TBL] [Abstract][Full Text] [Related]
95. Recognition and Differential Diagnosis of Hereditary Angioedema in the Emergency Department.
Pines JM; Poarch K; Hughes S
J Emerg Med; 2021 Jan; 60(1):35-43. PubMed ID: 33218838
[TBL] [Abstract][Full Text] [Related]
96. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
[TBL] [Abstract][Full Text] [Related]
97. Current and Emerging Therapeutics in Hereditary Angioedema.
Do T; Riedl MA
Immunol Allergy Clin North Am; 2024 Aug; 44(3):561-576. PubMed ID: 38937016
[TBL] [Abstract][Full Text] [Related]
98. Current treatment of hereditary angioedema: An update on clinical studies.
Banerji A
Allergy Asthma Proc; 2010; 31(5):398-406. PubMed ID: 20929607
[TBL] [Abstract][Full Text] [Related]
99. Psychological processes in the experience of hereditary angioedema in adult patients: an observational study.
Savarese L; Bova M; Maiello A; Petraroli A; Mormile I; Cancian M; Senter R; Zanichelli A; Spadaro G; Freda MF
Orphanet J Rare Dis; 2021 Jan; 16(1):23. PubMed ID: 33422102
[TBL] [Abstract][Full Text] [Related]
100. Hereditary Angioedema with Normal C1 Inhibitor and F12 Mutations in 42 Brazilian Families.
Veronez CL; Moreno AS; Constantino-Silva RN; Maia LSM; Ferriani MPL; Castro FFM; Valle SR; Nakamura VK; Cagini N; Gonçalves RF; Mansour E; Serpa FS; Coelho Dias GA; Piccirillo MA; Toledo E; de Souza Bernardes M; Cichon S; Stieber C; Arruda LK; Pesquero JB; Grumach AS
J Allergy Clin Immunol Pract; 2018; 6(4):1209-1216.e8. PubMed ID: 29128335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
